Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP781388.RAKTI9a2so7fnSe4IYo9HKIX1L85-WZlP0rkOedRB-rrQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP781388.RAKTI9a2so7fnSe4IYo9HKIX1L85-WZlP0rkOedRB-rrQ130_assertion type Assertion NP781388.RAKTI9a2so7fnSe4IYo9HKIX1L85-WZlP0rkOedRB-rrQ130_head.
- NP781388.RAKTI9a2so7fnSe4IYo9HKIX1L85-WZlP0rkOedRB-rrQ130_assertion description "[Therapy-related myelodysplasia and myeloid leukemia (t-MDS/t-AML) is a distinctive clinical syndrome occurring after exposure to chemotherapy (CT) or radiotherapy (RT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP781388.RAKTI9a2so7fnSe4IYo9HKIX1L85-WZlP0rkOedRB-rrQ130_provenance.
- NP781388.RAKTI9a2so7fnSe4IYo9HKIX1L85-WZlP0rkOedRB-rrQ130_assertion evidence source_evidence_literature NP781388.RAKTI9a2so7fnSe4IYo9HKIX1L85-WZlP0rkOedRB-rrQ130_provenance.
- NP781388.RAKTI9a2so7fnSe4IYo9HKIX1L85-WZlP0rkOedRB-rrQ130_assertion SIO_000772 12623843 NP781388.RAKTI9a2so7fnSe4IYo9HKIX1L85-WZlP0rkOedRB-rrQ130_provenance.
- NP781388.RAKTI9a2so7fnSe4IYo9HKIX1L85-WZlP0rkOedRB-rrQ130_assertion wasDerivedFrom befree-20150227 NP781388.RAKTI9a2so7fnSe4IYo9HKIX1L85-WZlP0rkOedRB-rrQ130_provenance.
- NP781388.RAKTI9a2so7fnSe4IYo9HKIX1L85-WZlP0rkOedRB-rrQ130_assertion wasGeneratedBy ECO_0000203 NP781388.RAKTI9a2so7fnSe4IYo9HKIX1L85-WZlP0rkOedRB-rrQ130_provenance.